Evidence map›Paper›PMID 42596663›Full record

ArticleMovement disorders clinical practice2026

Levodopa and Melanoma: Practical Recommendations for Parkinson's Disease-International Parkinson and Movement Disorder Society Scientific Issues Committee Viewpoint.

Giorgia Sciacca, Inas Elsayed, Santiago Perez-Lloret, Tiago F Outeiro, Vivek K Unni, Jeffery H Kordower, Daniela Berg, Lorraine V Kalia, MDS Scientific Issues Committee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giorgia SciaccaDepartment of Medical, Surgical Sciences and Advanced Technologies GF Ingrassia, University of Catania, Catania, Italy.ORCID https://orcid.org/0000-0002-1629-1282
Inas ElsayedFaculty of Pharmacy University of Gezira, Wadmadani, Sudan.
Santiago Perez-LloretObservatorio de Salud Pública, Calidad de Vida y Medio Ambiente, Facultad de Psicología y Psicopedagogía, Pontificia Universidad Católica Argentina, Consejo de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Tiago F OuteiroDepartment of Experimental Neurodegeneration, University Medical Center Göttingen, Center for Bio-structural Imaging of Neurodegeneration, Göttingen, Germany.ORCID https://orcid.org/0000-0003-1679-1727
Vivek K UnniDepartment of Neurology and Jungers Center for Neurosciences Research, Oregon Health and Science University, Portland, Oregon, USA.
Jeffery H KordowerASU-Banner Neurodegenerative Disease Research Center, Tempe, Arizona, USA.
Daniela BergDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Christian Albrechts-University of Kiel, Kiel, Germany.ORCID https://orcid.org/0000-0001-5796-5442
Lorraine V KaliaKrembil Brain Institute, Toronto Western Hospital, University Health Network (UHN), Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-9384-1305
MDS Scientific Issues Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancercausaldermatologicriskskin

Identifiers

PMID42596663
PMCPMC13473847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.